| __timestamp | Regeneron Pharmaceuticals, Inc. | Vertex Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 504755000 | 305409000 |
| Thursday, January 1, 2015 | 838526000 | 377080000 |
| Friday, January 1, 2016 | 1177697000 | 432829000 |
| Sunday, January 1, 2017 | 1320433000 | 496079000 |
| Monday, January 1, 2018 | 1556200000 | 557616000 |
| Tuesday, January 1, 2019 | 1834800000 | 658498000 |
| Wednesday, January 1, 2020 | 1346000000 | 770456000 |
| Friday, January 1, 2021 | 1824900000 | 840100000 |
| Saturday, January 1, 2022 | 2115900000 | 944700000 |
| Sunday, January 1, 2023 | 2631300000 | 1136600000 |
| Monday, January 1, 2024 | 2954400000 | 1464300000 |
In the competitive world of biotechnology, operational efficiency is key. Over the past decade, Regeneron Pharmaceuticals, Inc. and Vertex Pharmaceuticals Incorporated have demonstrated contrasting trends in their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, Regeneron's SG&A expenses surged by over 400%, peaking in 2023. This reflects their aggressive expansion and investment in administrative capabilities. In contrast, Vertex's SG&A expenses grew by approximately 270% during the same period, indicating a more conservative approach. Notably, in 2023, Regeneron's expenses were more than double those of Vertex, highlighting their differing strategic priorities. These trends offer a glimpse into how each company allocates resources to maintain their competitive edge in the biotech industry.
Merck & Co., Inc. vs Regeneron Pharmaceuticals, Inc.: SG&A Expense Trends
Selling, General, and Administrative Costs: Pfizer Inc. vs Vertex Pharmaceuticals Incorporated
Breaking Down SG&A Expenses: Vertex Pharmaceuticals Incorporated vs Zoetis Inc.
Research and Development Investment: Vertex Pharmaceuticals Incorporated vs Regeneron Pharmaceuticals, Inc.
Vertex Pharmaceuticals Incorporated and Teva Pharmaceutical Industries Limited: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? Vertex Pharmaceuticals Incorporated or Exelixis, Inc.
Operational Costs Compared: SG&A Analysis of Vertex Pharmaceuticals Incorporated and Opthea Limited
Selling, General, and Administrative Costs: Vertex Pharmaceuticals Incorporated vs Viridian Therapeutics, Inc.
Comparing SG&A Expenses: Regeneron Pharmaceuticals, Inc. vs Blueprint Medicines Corporation Trends and Insights
Comparing SG&A Expenses: Regeneron Pharmaceuticals, Inc. vs Corcept Therapeutics Incorporated Trends and Insights
Who Optimizes SG&A Costs Better? Regeneron Pharmaceuticals, Inc. or Merus N.V.
SG&A Efficiency Analysis: Comparing Regeneron Pharmaceuticals, Inc. and Amphastar Pharmaceuticals, Inc.